• Lead: Building Multidisciplinary Consensus on Inpatient Xylazine Management through Clinical Protocols

  • May 6 2025
  • Duración: 7 m
  • Podcast

Lead: Building Multidisciplinary Consensus on Inpatient Xylazine Management through Clinical Protocols

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Building Multidisciplinary Consensus on Inpatient Xylazine Management through Clinical Protocols

    Substance Use and Addiction Journal

    Xylazine in the unregulated drug supply produces significant morbidity and this paper describes utilizing a multidisciplinary team to develop protocols for inpatient setting to manage patients with xylazine exposure. Protocols developed included use of scheduled clonidine or tizanidine to manage withdrawal with hold parameters. As there is no FDA approved immunoassay screen, they recommended assuming xylazine exposure in areas with high prevalence and limited testing. The team also developed guidelines for cases in which surgical interventions would be considered, when to culture wounds, antibiotic usage, and consistent wound care based on size and clinical characteristics. In addition, they developed standardized discharge instructions, including referral to substance use disorder treatment, harm reduction and education around xylazine test strip use.

    Read this issue of the ASAM Weekly

    Subscribe to the ASAM Weekly

    Visit ASAM
    Más Menos
Más Menos
adbl_web_global_use_to_activate_webcro805_stickypopup

Lo que los oyentes dicen sobre Lead: Building Multidisciplinary Consensus on Inpatient Xylazine Management through Clinical Protocols

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles